论文部分内容阅读
对黄芪注射液联合血脂康治疗高脂血症合并高粘血症40例进行了临床观察,并对治疗前后血脂、血液流变学指标进行了统计对照,现报告如下。 一、资料和方法 1.病例选择:40例忠者均根据其可靠病史及反复实验室检查而确诊,近2周内未服用任何降脂药物并能配合治疗。其中男性24例,女性16例;年龄34～72岁,平均50.2岁。合并高血压病15例,冠心病10例,椎-基底动脉供血
Astragalus injection of Xuezhikang treatment of hyperlipidemia with hyperviscosity 40 cases of clinical observation, and before and after treatment of blood lipids, hemorheological indicators were statistically controlled, are as follows. First, the data and methods 1. Case selection: 40 loyal persons were confirmed according to their reliable history and repeated laboratory tests, within the past 2 weeks did not take any lipid-lowering drugs and can cooperate with the treatment. Including 24 males and 16 females; aged 34 to 72 years, mean 50.2 years old. 15 cases of hypertension, coronary heart disease in 10 cases, vertebrobasilar artery blood supply